Abbott Laboratories (ABT)
118.60
+5.23
(+4.61%)
USD |
NYSE |
Nov 01, 16:00
119.14
+0.54
(+0.46%)
After-Hours: 20:00
Abbott Laboratories Total Liabilities (Quarterly): 34.33B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 34.33B |
| June 30, 2024 | 33.46B |
| March 31, 2024 | 33.42B |
| December 31, 2023 | 34.39B |
| September 30, 2023 | 34.40B |
| June 30, 2023 | 35.95B |
| March 31, 2023 | 36.56B |
| December 31, 2022 | 37.53B |
| September 30, 2022 | 36.92B |
| June 30, 2022 | 37.49B |
| March 31, 2022 | 38.38B |
| December 31, 2021 | 39.17B |
| September 30, 2021 | 39.16B |
| June 30, 2021 | 39.24B |
| March 31, 2021 | 39.00B |
| December 31, 2020 | 39.54B |
| September 30, 2020 | 37.45B |
| June 30, 2020 | 37.98B |
| March 31, 2020 | 36.35B |
| December 31, 2019 | 36.59B |
| September 30, 2019 | 36.52B |
| June 30, 2019 | 36.53B |
| March 31, 2019 | 36.48B |
| December 31, 2018 | 36.45B |
| September 30, 2018 | 40.74B |
| Date | Value |
|---|---|
| June 30, 2018 | 37.64B |
| March 31, 2018 | 39.31B |
| December 31, 2017 | 45.15B |
| September 30, 2017 | 40.03B |
| June 30, 2017 | 39.36B |
| March 31, 2017 | 39.34B |
| December 31, 2016 | 31.95B |
| September 30, 2016 | 18.60B |
| June 30, 2016 | 19.04B |
| March 31, 2016 | 18.80B |
| December 31, 2015 | 19.92B |
| September 30, 2015 | 20.51B |
| June 30, 2015 | 21.00B |
| March 31, 2015 | 21.11B |
| December 31, 2014 | 19.57B |
| September 30, 2014 | 19.52B |
| June 30, 2014 | 17.77B |
| March 31, 2014 | 18.17B |
| December 31, 2013 | 17.69B |
| September 30, 2013 | 20.34B |
| June 30, 2013 | 20.48B |
| March 31, 2013 | 20.00B |
| December 31, 2012 | 40.42B |
| September 30, 2012 | 36.15B |
| June 30, 2012 | 37.29B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
33.42B
Minimum
Mar 2024
39.54B
Maximum
Dec 2020
36.86B
Average
37.18B
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 16.50B |
| Becton Dickinson & Co | 29.71B |
| ResMed Inc | 2.027B |
| Integra Lifesciences Holdings Corp | 2.540B |
| QuidelOrtho Corp | 3.516B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 74.36B |
| Shareholders Equity (Quarterly) | 39.80B |
| Debt to Equity Ratio | 0.3764 |
| Current Ratio | 1.597 |
| Net Debt Paydown Yield | 0.19% |